Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2179897 | 0.90 | TSHR (0.59) | MAOBMAOATSHRALDH1A1L3MBTL1 | |
| SCHEMBL9669685 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPTCA2CA1KMT2A | |
| SCHEMBL4078022 | 0.81 | CA2 (0.58) | MAOBMAOATSHRALDH1A1LMNA | |
| SCHEMBL154636 | 0.78 | — | — | |
| Water SCHEMBL27994834 | 0.78 | MAOB (0.73) | MAOBMAOATSHRALDH1A1GSK3B | |
| Benzoic Acid SCHEMBL4232492 | 0.77 | MAP4K4 (0.47) | TSHRALDH1A1L3MBTL1LMNAMAPT | |
| SCHEMBL23456757 | 0.77 | TSHR (0.59) | MAOBMAOATSHRALDH1A1L3MBTL1 | |
| SCHEMBL21783611 | 0.77 | TSHR (0.59) | MAOBMAOATSHRALDH1A1L3MBTL1 | |
| SCHEMBL21783604 | 0.77 | TSHR (0.59) | MAOBMAOATSHRALDH1A1L3MBTL1 | |
| SCHEMBL21783558 | 0.77 | TSHR (0.59) | MAOBMAOATSHRALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172529-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES S.A. (ES) | 2013-07-04 | — | — | US | disclosed |
| EP-2019118-B1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES SA (ES) | 2012-11-07 | — | — | EP | disclosed |
| US-20110166071-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES S.A. (ES) | 2011-07-07 | — | — | US | disclosed |
| EP-2019118-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN Peptides, S.A. (ES) | 2009-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166071-A1 | METHOD FOR SYNTHESIZING THYMOSINS | PTMS, PTMA, VIP | MAOB 3975/4885MAOA 3539/4885TSHR 152/4885 |
| US-20130172529-A1 | METHOD FOR SYNTHESIZING THYMOSINS | PTMS, PTMA, VIP | MAOB 3975/4885MAOA 3539/4885TSHR 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.